RESUMEN
We present experimental results on intrinsic 1/f frequency modulation (FM) noise in high-overtone thin-film sapphire resonators that operate at 2 GHz. The resonators exhibit several high-Q resonant modes approximately 100 kHz apart, which repeat every 13 MHz. A loaded Q of approximately 20,000 was estimated from the phase response. The results show that the FM noise of the resonators varied between Sy (10 Hz) = -202 dB relative (rel) to 1/Hz and -210 dB rel to 1/Hz. The equivalent phase modulation (PM) noise of an oscillator using these resonators (assuming a noiseless amplifier) would range from [symbol: see text](10 Hz) = -39 to -47 dBc/Hz.
RESUMEN
The effects of fluorodeoxy prostanoids on platelet aggregability were studied. It was shown that introduction of fluorine into positions 9, 11 or 15 of prostaglandin F2 alpha led to enhanced proaggregation activity. The most active compound among fluorodeoxy analogs was 15-fluoro derivative; bisfluoro analog was moderately active, and 11-fluoro compound had the least activity. In the group of fluorodeoxy prostaglandins E2, a contrary effect was registered. Thus, the most active compound was 1-fluoride and the least, 15-fluoride. The incorporation of fluorine into position 15 of prostacyclin led to insignificantly lower antiaggregatory activity just as this modification of 6-keto-prostaglandin F1 alpha was accompanied by a dramatic increase in its ability to inhibit platelet aggregation.
Asunto(s)
Agregación Plaquetaria/efectos de los fármacos , Prostaglandinas Sintéticas/farmacología , Adenosina Difosfato/farmacología , Animales , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Conejos , Relación Estructura-ActividadRESUMEN
The authors examined the ratios of blood free polyunsaturated fatty acids (PUFA), such as 20:3n6, 20:4n6, 20:5n3, and 22:6n3, which are substrates and inhibitors of synthesis of thromboxane A2 and prostacyclins that regulate both normal blood fluidity, and platelet adhesion and primary thrombogenesis. The object of the study was plasma from healthy subjects and 4 groups of patients with cardiovascular diseases: 1) large myocardial infarction; 2) resting and exercise-induced angina pectoris; 3) large myocardial infarction; and 4) recurrent myocardial infarction. The levels of plasma free PUFA were measured by gas chromatography. Assessment of the PUFA ratios indicated that the risk for thrombogenesis increased in large and recurrent myocardial infarctions as compared to small myocardial infarction and angina pectoris both by reducing the relative levels of 20:3n6 and, in particular, 20:5n3, substrates of synthesis of only thrombolytics and vasodilators and by more greatly inhibiting the synthesis of prostacyclins than thromboxane with elevated 22:6n3 levels.
Asunto(s)
Enfermedad Coronaria/sangre , Epoprostenol/antagonistas & inhibidores , Ácidos Grasos Insaturados/sangre , Tromboxano A2/antagonistas & inhibidores , Anciano , Anciano de 80 o más Años , Angina de Pecho/sangre , Cromatografía de Gases , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/sangre , RecurrenciaRESUMEN
The work deals with the study of the mosaic character of the hemostatic potential, connected with the development of a localized pathological process, taking postmastectomy edema in illustration. It is shown that this condition is an example of the manifestation of the RASK system mosaics in one organism in pathology. It should be pointed out that the degree of the development of the local DVS syndrome changes significantly some of the RASK system parameters at the level of the whole organism. This is evidence that normalization of the microcirculatory processes in the edematous extremity will be an important measure in complex treatment of postmastectomy edema. It will considerably lower the risk of general disorders of the RASK system. Parameters determined in the blood collected from the extremity on the side of the operation will serve as controls of the efficacy of the applied therapeutic measures.
Asunto(s)
Brazo/irrigación sanguínea , Coagulación Sanguínea/fisiología , Neoplasias de la Mama/cirugía , Coagulación Intravascular Diseminada/etiología , Linfedema/etiología , Mastectomía Radical/efectos adversos , Complicaciones Posoperatorias/etiología , Neoplasias de la Mama/sangre , Femenino , Humanos , Linfedema/sangreRESUMEN
The review presents the literature data on the peculiarities of effects of the drugs administered in the systemic blood flow by using application to different areas of the oral mucosa.
Asunto(s)
Boca/metabolismo , Farmacocinética , Absorción , Administración Bucal , Disponibilidad Biológica , Permeabilidad de la Membrana Celular/efectos de los fármacos , Permeabilidad de la Membrana Celular/fisiología , Humanos , Mucosa Bucal/metabolismo , SolucionesAsunto(s)
Inhibidores de Agregación Plaquetaria/farmacología , Agregación Plaquetaria/efectos de los fármacos , Evaluación de Medicamentos , Epoprostenol/biosíntesis , Humanos , Factor de Activación Plaquetaria/antagonistas & inhibidores , Estimulación Química , Tromboxano A2/antagonistas & inhibidores , Tromboxano A2/biosíntesisAsunto(s)
Factor de Activación Plaquetaria/farmacología , Inhibidores de Agregación Plaquetaria/farmacología , Agregación Plaquetaria/efectos de los fármacos , Glicoproteínas de Membrana Plaquetaria , Receptores Acoplados a Proteínas G , Animales , Plaquetas/efectos de los fármacos , Fenómenos Químicos , Química , Humanos , Inhibidores de Agregación Plaquetaria/uso terapéutico , Receptores de Superficie Celular/efectos de los fármacos , Relación Estructura-ActividadAsunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Agregación Plaquetaria/efectos de los fármacos , Animales , Plaquetas/efectos de los fármacos , Plaquetas/metabolismo , Calcio/sangre , Calmodulina/antagonistas & inhibidores , AMP Cíclico/sangre , Depresión Química , Humanos , Factor de Activación Plaquetaria/antagonistas & inhibidoresRESUMEN
The influence of non-steroidal antiphlogistics (NSA, fluor derivatives of phenylanthranilic acid) on fibrinolysis, platelet function, prostaglandin metabolism and pharmacokinetics of indirect anticoagulants was studied in rats and rabbits in vitro and in vivo. NSA were found to shorten the euglobulin lysis time and to enlarge the lysis zones on fibrin plates. They potentiated the fibrinolytic activity of streptokinase and trypsin. Furthermore, they inhibited platelet aggregation induced by arachidonic acid in rabbits. NSA in combination with inhibitors of thromboxane synthetase potentiated inhibition of aggregation. After oral administration, NSA inhibited formation of thromboxane A2 and prostacyclin in rabbits in a dose-dependent manner. At comparatively low doses, thromboxane A2 synthesis was more effectively inhibited than prostacyclin formation. Due to pharmacokinetic interactions NSA enhanced the anticoagulant effect of indirect anticoagulants and accelerated their distribution and elimination.
Asunto(s)
Antiinflamatorios/farmacología , Fibrinólisis/efectos de los fármacos , Agregación Plaquetaria/efectos de los fármacos , Animales , Anticoagulantes/farmacología , Ácido Araquidónico , Ácidos Araquidónicos/farmacología , Cinética , Prostaglandinas/sangre , ConejosAsunto(s)
Brazo , Linfedema/terapia , Mastectomía/efectos adversos , Terapia Combinada , Femenino , Humanos , Linfedema/etiologíaRESUMEN
Anthryl-labeled fluorescent probes closely mimicking phosphatidylcholine and sphingomyelin were applied to study the state of these phospholipids in the rabbit erythrocyte membrane. At normal cholesterol levels both probes exhibited higher fluorescence polarization values in the membranes than in phospholipid vesicles of similar lipid composition, indicating a decreased fluidity of the probe environment in erythrocyte ghosts. In ghosts prepared from normal erythrocytes no evidence of lateral separation of phosphatidylcholine and sphingomyelin was found. At higher cholesterol levels, however, these lipids appear to segregate. Probably the effect of cholesterol on the erythrocyte membrane lipids involves lipid-protein interactions. At physiological concentrations, prostaglandin E1 only weakly affects the state of phosphatidylcholine and sphingomyelin in erythrocyte membranes. Cholesterol enrichment amplifies the effect of prostaglandin E1. Although the prostaglandin E1-induced changes depended much upon whether the ghosts were enriched with cholesterol in vitro or in vivo, with both types of ghosts effects of prostaglandin E1 were seen at extremely low effector concentrations that may have presented a few molecules of prostaglandin per ghost. The structural and functional significance of these findings is discussed.